As the Australian population ages the burden of dementia is increasing. Conventional drug treatment only provides modest benefits for patients, so patients and their carers often turn to complementary medicines. early trials showed promise for some compounds but larger better conducted studies have usually failed to confirm these benefits. However, there have been few large-scale interventions using complementary medicines for cognition. Health professionals should always ask patients (and their carers) if complementary medicines are being taken because adverse effects and interactions with conventional drugs can occur.
Ginkgo biloba
There are 122 products whose name contains Ginkgo biloba listed on the Australian Register of Therapeutic Goods (ARTG).
It is one of the commonest herbal medicines taken to prevent or treat cognitive impairment. Claims include, 'helps to improve blood flow to the brain' and 'improves memory and cognitive function'. There is some evidence that taking ginkgo leaf extract orally modestly improves symptoms of Alzheimer's, vascular, or mixed dementias, but this comes from poor quality studies. 4 A study, funded by the US National Center for Complementary and Alternative Medicine, of the well-characterised ginkgo product EGb-761 found it ineffective in lowering the overall incidence of dementia and Alzheimer's disease in the elderly.
Further analysis also found ginkgo to be ineffective in slowing cognitive decline. This trial recruited more than 3000 volunteers aged 75 and over who took 240 mg of ginkgo daily, and followed them for around six years. 5, 6 Some smaller studies for www.australianprescriber.com memory enhancement have had promising results, but a trial sponsored by the US National Institute on Aging of more than 200 healthy adults over age 60 found that ginkgo taken for six weeks did not improve memory. 7 A recent press release reports that the IPSEN GuidAge study, involving 2854 participants aged 70 years or older complaining of memory problems, showed a statistically significant decrease in progression to Alzheimer's disease. The study authors conclude that the difference between their results and those of the earlier US study is due to differences in compliance. 8 Alzheimer's disease. 10 While oral vitamin E seldom causes immediate adverse effects, another Cochrane review suggested that vitamin E supplementation may increase mortality. 11
Brahmi and Gotu Kola
There are 32 products on the ARTG whose names include While adverse effects appear uncommon, there have been three cases of hepatotoxicity associated with Gotu Kola. 13 There are some reports of changes in bowel function with bacopa extract. 12
Acetyl-L-carnitine
There are 26 products containing acetyl-L-carnitine listed on the ARTG. They make claims such as, 'helps maintain healthy cognitive function and memory during ageing' and 'may provide protective effects against age related processes and neurodegeneration'. Acetyl-L-carnitine is structurally related to acetylcholine and it was thought it might act as an analogue of 
